Literature DB >> 34314071

Proteome signature difference between respiratory viruses is associated with severity of bronchiolitis.

Tadao Ooka1,2, Yoshihiko Raita1, Debby Ngo3, Jonathan M Mansbach4, Zhaozhong Zhu1, Carlos A Camargo1, Kohei Hasegawa1.   

Abstract

Entities:  

Keywords:  bronchiolitis; proteome; respiratory syncytial virus; rhinovirus; severity

Mesh：

Substances：

Year:  2021        PMID： 34314071      PMCID： PMC8561626          DOI： 10.1111/pai.13606

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN： 0905-6157            Impact factor:   6.377


× No keyword cloud information.
  10 in total

Review 1.  Advancing our understanding of infant bronchiolitis through phenotyping and endotyping: clinical and molecular approaches.

Authors:  Kohei Hasegawa; Orianne Dumas; Tina V Hartert; Carlos A Camargo
Journal:  Expert Rev Respir Med       Date:  2016-06-16       Impact factor: 3.772

2.  Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota.

Authors:  Jonathan M Mansbach; Kohei Hasegawa; David M Henke; Nadim J Ajami; Joseph F Petrosino; Chad A Shaw; Pedro A Piedra; Ashley F Sullivan; Janice A Espinola; Carlos A Camargo
Journal:  J Allergy Clin Immunol       Date:  2016-04-06       Impact factor: 10.793

3.  Genetic susceptibility to respiratory syncytial virus bronchiolitis is predominantly associated with innate immune genes.

Authors:  Riny Janssen; Louis Bont; Christine L E Siezen; Hennie M Hodemaekers; Marieke J Ermers; Gerda Doornbos; Ruben van 't Slot; Ciska Wijmenga; Jelle J Goeman; Jan L L Kimpen; Hans C van Houwelingen; Tjeerd G Kimman; Barbara Hoebee
Journal:  J Infect Dis       Date:  2007-08-10       Impact factor: 5.226

4.  Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Authors:  Caroline E Sutton; Stephen J Lalor; Cheryl M Sweeney; Corinna F Brereton; Ed C Lavelle; Kingston H G Mills
Journal:  Immunity       Date:  2009-08-13       Impact factor: 31.745

Review 5.  Infectious pathogens and bronchiolitis outcomes.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Carlos A Camargo
Journal:  Expert Rev Anti Infect Ther       Date:  2014-04-04       Impact factor: 5.091

6.  New Strategies and Challenges in Lung Proteomics and Metabolomics. An Official American Thoracic Society Workshop Report.

Authors:  Russell P Bowler; Chris H Wendt; Michael B Fessler; Matthew W Foster; Rachel S Kelly; Jessica Lasky-Su; Angela J Rogers; Kathleen A Stringer; Brent W Winston
Journal:  Ann Am Thorac Soc       Date:  2017-12

7.  The role of interleukin-1 and interleukin-18 in pro-inflammatory and anti-viral responses to rhinovirus in primary bronchial epithelial cells.

Authors:  Siân C Piper; John Ferguson; Linda Kay; Lisa C Parker; Ian Sabroe; Matthew A Sleeman; Emmanuel Briend; Donna K Finch
Journal:  PLoS One       Date:  2013-05-28       Impact factor: 3.240

8.  Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection.

Authors:  Asuncion Mejias; Blerta Dimo; Nicolas M Suarez; Carla Garcia; M Carmen Suarez-Arrabal; Tuomas Jartti; Derek Blankenship; Alejandro Jordan-Villegas; Monica I Ardura; Zhaohui Xu; Jacques Banchereau; Damien Chaussabel; Octavio Ramilo
Journal:  PLoS Med       Date:  2013-11-12       Impact factor: 11.069

9.  In infants with severe bronchiolitis: dual-transcriptomic profiling of nasopharyngeal microbiome and host response.

Authors:  Michimasa Fujiogi; Carlos A Camargo; James P Bernot; Robert J Freishtat; Brennan Harmon; Jonathan M Mansbach; Eduardo Castro-Nallar; Marcos Perez-Losada; Kohei Hasegawa
Journal:  Pediatr Res       Date:  2020-01-06       Impact factor: 3.756

10.  Respiratory Syncytial Virus induces the classical ROS-dependent NETosis through PAD-4 and necroptosis pathways activation.

Authors:  Stéfanie P Muraro; Gabriela F De Souza; Stephanie W Gallo; Bruna K Da Silva; Sílvia D De Oliveira; Marco Aurélio R Vinolo; Elvira M Saraiva; Bárbara N Porto
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.